Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,100 public trials 1,371 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

NCT01794793

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +50 more
Locations
  • Ximed Research SC - SOM230B2412 La Jolla, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
  • Stanford Universtiy Medical Center Stanford Hospital & Clinics Stanford, California, United States
  • University of Michigan Comprehensive Cancer Center SC-2 Ann Arbor, Michigan, United States
View all 94 locations
View Trial Details
Completed

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

NCT02791334

Conditions
Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • The START Center for Cancer Care San Antonio, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 14 locations
View Trial Details
Completed

A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors

NCT04672460

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Cancer, +40 more
Locations
  • California Cancer Associates for Research and Excellence, Inc (cCARE) Encinitas, California, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Cancer Associates for Research and Excellence, Inc (cCARE) San Marcos, California, United States
View all 31 locations
View Trial Details
Completed

STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma

NCT04098432

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Klinika Onkologie a radioterapie, Fakultní nemocnice Hradec Králové Hradec Králové, Czechia
  • Onkologická klinika, Fakultní nemocnice Olomouc Olomouc, Czechia
  • Onkologická klinika, Thomayerova nemocnice Prague, Czechia
  • Ústav radiační onkologie, Nemocnice Na Bulovce Prague, Czechia
View Trial Details
Completed

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

NCT03648489

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • Charité Universitätsmedizin Berlin Berlin, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
  • KEM Kliniken Essen-Mitte Essen, Germany
  • Furness General Hospital Barrow in Furness, Cumbria, United Kingdom
View all 15 locations
View Trial Details
Completed

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

NCT02903771

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Peggy and Charles Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, Oklahoma, United States
  • Lifespan Cancer Institute, Rhode Island Hospital Providence, Rhode Island, United States
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
  • Westmead Adults Hospital Westmead, New South Wales, Australia
View Trial Details

Related conditions